Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£102K-£18M
Sector
HEALTH
Published
23 Aug 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 67 suppliers

Description

This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into eleven (11) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this notice.

Lot Division

1 Desferrioxamine Injections

Supply of Desferrioxamine Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

2 Dexamethasone Injections

The Supply of Dexamethasone Injections The Authority has awarded each product line as an unranked multi-supplier framework agreement to six (6) Framework Participants

3 Macrogol Oral Powder & Solutions

The Supply of Macrogol Oral Powder & Solutions The Authority has awarded each product line as an unranked multi-supplier framework agreement to three (3) Framework Participants

4 Mesalazine

The Supply of Mesalazine to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to six (6) Framework Participants

5 Magnesium Sulfate

The supply of Magnesium sulfate to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to two (2) Framework Participants

6 Calcium Carbonate Tablets

The Supply of Calcium Carbonate Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to three (3) Framework Participants.

7 Budesonide

The supply of Budesonide to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to two (2) Framework Participants

9 Pancreatin

The supply of Pancreatin to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to two (2) Framework Participants

10 All Other Presentations

Supply of all other products/presentations within this tender to NHS Scotland. Each product line was treated as an individual Lot, and the Authority has awarded each lot to a single framework participant.

11 Trientine

Supply of Trientine within this tender to NHS Scotland. Each product line was treated as an individual Lot, and has been awarded to a single Framework Participant.

Award Detail

1 Kent Pharmaceuticals (Ashford)
  • Lot 1 Desferrioxamine Injections
  • Reference: 020715-2021-1
  • Value: £279,133
2 Norgine Pharmaceuticals (Uxbridge)
  • Lot 3 Macrogol Oral Powder & Solutions
  • Reference: 020715-2021-2
  • Value: £1,945,067 [share]
  • Awarded to group of suppliers.
3 Tillotts Pharmaltd (Lincoln)
  • Lot 3 Macrogol Oral Powder & Solutions
  • Reference: 020715-2021-2
  • Value: £1,945,067 [share]
  • Awarded to group of suppliers.
4 Galen (Craigavon)
  • Lot 3 Macrogol Oral Powder & Solutions
  • Reference: 020715-2021-2
  • Value: £1,945,067 [share]
  • Awarded to group of suppliers.
5 Martindale Pharma (Romford)
  • Lot 5 Magnesium Sulfate
  • Reference: 020715-2021-3
  • Value: £276,158 [share]
  • Awarded to group of suppliers.
6 Kent Pharmaceuticals (Ashford)
  • Lot 5 Magnesium Sulfate
  • Reference: 020715-2021-3
  • Value: £276,158 [share]
  • Awarded to group of suppliers.
7 Kyowa Kirin (Galashiels)
  • Lot 6 Calcium Carbonate Tablets
  • Reference: 020715-2021-4
  • Value: £140,341 [share]
  • Awarded to group of suppliers.
8 Thornton & Ross (Huddersfield)
  • Lot 6 Calcium Carbonate Tablets
  • Reference: 020715-2021-4
  • Value: £140,341 [share]
  • Awarded to group of suppliers.
9 Accord (Devon)
  • Lot 6 Calcium Carbonate Tablets
  • Reference: 020715-2021-4
  • Value: £140,341 [share]
  • Awarded to group of suppliers.
10 Tillotts Pharmaltd (Lincoln)
  • Lot 7 Budesonide
  • Reference: 020715-2021-5
  • Value: £102,457 [share]
  • Awarded to group of suppliers.
11 DR Falk Pharma (Bucks)
  • Lot 7 Budesonide
  • Reference: 020715-2021-5
  • Value: £102,457 [share]
  • Awarded to group of suppliers.
12 Mylan (Hatfield)
  • Lot 9 - Pancreatin
  • Reference: 020715-2021-6
  • Value: £578,169 [share]
  • Awarded to group of suppliers.
13 Zentiva Pharma (London)
  • Lot 9 - Pancreatin
  • Reference: 020715-2021-6
  • Value: £578,169 [share]
  • Awarded to group of suppliers.
14 Univar Solutions (Bradford)
  • Lot 11 Trientine
  • Reference: 020715-2021-7
  • Value: £210,000 [share]
  • Awarded to group of suppliers.
15 Tillomed Laboratories (Luton)
  • Lot 11 Trientine
  • Reference: 020715-2021-7
  • Value: £210,000 [share]
  • Awarded to group of suppliers.
16 Orphalan (London)
  • Lot 11 Trientine
  • Reference: 020715-2021-7
  • Value: £210,000 [share]
  • Awarded to group of suppliers.
17 Kent Pharmaceuticals (Ashford)
  • Lot 2 Dexamethasone Injections
  • Reference: 020715-2021-8
  • Value: £1,497,591 [share]
  • Awarded to group of suppliers.
18 Hameln Pharma (Gloucester)
  • Lot 2 Dexamethasone Injections
  • Reference: 020715-2021-8
  • Value: £1,497,591 [share]
  • Awarded to group of suppliers.
19 Consilient Health (Richmond)
  • Lot 2 Dexamethasone Injections
  • Reference: 020715-2021-8
  • Value: £1,497,591 [share]
  • Awarded to group of suppliers.
20 Panpharma (Liverpool)
  • Lot 2 Dexamethasone Injections
  • Reference: 020715-2021-8
  • Value: £1,497,591 [share]
  • Awarded to group of suppliers.
21 Pfizer (Tadworth)
  • Lot 2 Dexamethasone Injections
  • Reference: 020715-2021-8
  • Value: £1,497,591 [share]
  • Awarded to group of suppliers.
22 Wockhardt (Wrexham)
  • Lot 2 Dexamethasone Injections
  • Reference: 020715-2021-8
  • Value: £1,497,591 [share]
  • Awarded to group of suppliers.
23 Accord (Devon)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
24 Baxter Healthcare (Berkshire)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
25 Bowmed Ibisqus (Wrexham)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
26 Consilient Health (Richmond)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
27 Colonis Pharma (Burnopfield)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
28 Brown & Burk (West London)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
29 Crescent Pharma (Basingstoke)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
30 CST Pharma (Walsall)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
31 DR Falk Pharma (Bucks)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
32 Ennogen Healthcare (Dartford)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
33 Ferring Pharmaceuticals (West Drayton)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
34 Focus Pharmaceuticals (Burton upon Trent)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
35 Galen (Craigavon)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
36 Glaxosmithkline (Uxbridge)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
37 Glenmark Pharmaceuticals Europe (Watford)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
38 Hameln Pharma (Gloucester)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
39 Intrapharm Laboratories (Maidenhead)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
40 Kent Pharmaceuticals (Ashford)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
41 Kyowa Kirin (Galashiels)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
42 Martindale Pharma (Romford)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
43 Medreich (Middlesex)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
44 Mercury Pharma Group (Croydon)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
45 Morningside Pharmaceuticals (Leicestershire)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
46 Mylan (Hatfield)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
47 Pfizer (Tadworth)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
48 Ranbaxy (London)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
49 Reckitt Benckiser (Slough)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
50 Rosemont Pharmaceuticals (Leeds)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
51 Sandoz (Camberley)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
52 Seacross Pharmaceuticals (Bedford)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
53 Selective Supplies (Haywards Heath)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
54 Synchrony Pharma (Stevenage)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
55 Teva (Castleford)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
56 Thornton & Ross (Huddersfield)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
57 Tillomed Laboratories (Luton)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
58 Typharm (Norwich)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
59 Wockhardt (Wrexham)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
60 Zentiva Pharma (London)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
61 Eurocept (Ankeveen)
  • Lot 10 All Other Presentations
  • Reference: 020715-2021-9
  • Value: £18,378,855 [share]
  • Awarded to group of suppliers.
62 DR Falk Pharma (Bucks)
  • Lot 4 Mesalazine
  • Reference: 020715-2021-10
  • Value: £237,964 [share]
  • Awarded to group of suppliers.
63 Ferring Pharmaceuticals (West Drayton)
  • Lot 4 Mesalazine
  • Reference: 020715-2021-10
  • Value: £237,964 [share]
  • Awarded to group of suppliers.
64 Tillotts Pharmaltd (Lincoln)
  • Lot 4 Mesalazine
  • Reference: 020715-2021-10
  • Value: £237,964 [share]
  • Awarded to group of suppliers.
65 Morningside Pharmaceuticals (Leicestershire)
  • Lot 4 Mesalazine
  • Reference: 020715-2021-10
  • Value: £237,964 [share]
  • Awarded to group of suppliers.
66 Allergan (Marlow)
  • Lot 4 Mesalazine
  • Reference: 020715-2021-10
  • Value: £237,964 [share]
  • Awarded to group of suppliers.
67 Takeda (Bucks)
  • Lot 4 Mesalazine
  • Reference: 020715-2021-10
  • Value: £237,964 [share]
  • Awarded to group of suppliers.

Award Criteria

Logistics 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value referred to in Sections II.I.5 and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options. The Authority has not awarded any products within Lot 8 Vitamins with Minerals and Trace elements as no bids received. (SC Ref:662986)

Reference

Domains